While one section of the initial Centers for Medicare and Medicaid Services guidance on the drug price negotiation program is final, the agency is actively seeking comment, if quickly, on several other elements.
The 91-page guidance was released 15 March with a narrow 30-day window for public comments, which are due by 14...







